About: BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.38 (-0.24%)
BLSM NASDAQ BlossomHill Therapeutics, Inc. Common Stock
BlossomHill Therapeutics, Inc. Common Stock share price
Atividade de preço de BLSM
Último preço
$ 12,380
Variação (24h)
-0,03 USD (0,24%)
Volume
297.39K
Volume (média 4 sem.)
-
Abertura
$ 12,45
Variação do dia
$ 11,24 - $ 13,00
Fechamento anterior
$ 12,41
Último negócio
04 Nov, 9:00 pm GMT+0
Atrasado
04 Nov, 9:00 pm GMT+0
BLSM price performance
Atrasado
04 Nov, 9:00 pm GMT+0
BLSM details
quote.marketSignals